The purpose of this study is to investigate liver embolization techniques for managing primary and secondary hepatic tumors. This study focuses on patients who have tumors that cannot be removed by surgery or ablation.
This study evaluates the outcomes of different embolization methods, such as progression-free survival and liver regeneration. It observes how these techniques affect tumor management over time.
- Who can participate: Adults aged 18 and older with primary or secondary liver tumors that are not suitable for surgery or ablation can participate. Participants must be able and willing to sign informed consent.
- Study details: Participants will undergo liver embolization as part of their standard care. This study does not involve additional interventions beyond regular clinical practice.
How understandable was the trial content above?
Hard to understand
Easy to understand